• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增生异常综合征:护士须知

Myelodysplastic syndromes: a review for nurses.

作者信息

Cain J, Hood-Barnes J, Spangler J

机构信息

Uniontown Hospital, PA.

出版信息

Oncol Nurs Forum. 1991 Jan-Feb;18(1):113-7.

PMID:2003103
Abstract

The Myelodysplastic Syndromes (MDS) are a group of hematologic disorders that resemble hematologic malignancies but are often treated much differently. These syndromes result from a clonal disorder of certain stem cells in the bone marrow. Treatment can range from simple supportive care to new and innovative approaches such as immunotherapy. In general, treatment is dictated by the severity of the presenting disease. Oncology nurses, because of their familiarity with the manifestations of cancer, are particularly qualified to intervene for the patient and family experiencing MDS. Nursing interventions, based on a firm understanding of the underlying disease, include patients and family education. In addition, emotional support and symptom management are important nursing roles.

摘要

骨髓增生异常综合征(MDS)是一组血液系统疾病,它们类似于血液系统恶性肿瘤,但治疗方式通常大不相同。这些综合征源于骨髓中某些干细胞的克隆性疾病。治疗方法从简单的支持性护理到免疫疗法等新的创新方法不等。一般来说,治疗取决于所呈现疾病的严重程度。肿瘤学护士由于熟悉癌症的表现,特别有资格为患有MDS的患者及其家属提供干预。基于对潜在疾病的深入理解,护理干预措施包括对患者及其家属的教育。此外,情感支持和症状管理也是重要的护理职责。

相似文献

1
Myelodysplastic syndromes: a review for nurses.骨髓增生异常综合征:护士须知
Oncol Nurs Forum. 1991 Jan-Feb;18(1):113-7.
2
Myelodysplasia: clinical and morphological aspects and treatment.
Bone Marrow Transplant. 1989 Jan;4 Suppl 1:138-40.
3
[The myelodysplastic syndrome II. New therapeutic principles, course and prognosis].[骨髓增生异常综合征II。新的治疗原则、病程及预后]
Ugeskr Laeger. 2002 Jan 21;164(4):479-82.
4
Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.骨髓增生异常综合征的支持性治疗及造血生长因子的应用
Semin Hematol. 2008 Jan;45(1):14-22. doi: 10.1053/j.seminhematol.2007.10.004.
5
Emerging data on IMiDs in the treatment of myelodysplastic syndromes (MDS).关于免疫调节药物(IMiDs)治疗骨髓增生异常综合征(MDS)的新数据。
Semin Oncol. 2005 Aug;32(4 Suppl 5):S31-5. doi: 10.1053/j.seminoncol.2005.06.020.
6
The treatment of myelodysplastic syndromes.
Clin Haematol. 1986 Nov;15(4):1081-107.
7
Advances in supportive care of myelodysplastic syndromes.骨髓增生异常综合征支持性治疗的进展
Semin Hematol. 1999 Oct;36(4 Suppl 6):21-4.
8
Physician Education: Myelodysplastic Syndrome.医师教育:骨髓增生异常综合征
Oncologist. 1996;1(4):284-287.
9
Myelodysplastic syndromes: the challenge of developing clinical guidelines and supportive care strategies for a rare disease.
Clin J Oncol Nurs. 2012 Jun;16 Suppl:5-7. doi: 10.1188/12.CJON.S1.5-7.
10
Managing patients with low-risk MDS.低危骨髓增生异常综合征患者的管理
Clin Adv Hematol Oncol. 2006 Jul;4(7 Suppl 16):1-10; quiz 11-2.